. Author manuscript; available in PMC: 2019 Sep 1.

Published in final edited form as: J Pain. 2018 Apr 17;19(9):1049–1062. doi: 10.1016/j.jpain.2018.04.003

Table 4.

Age-adjusted mean scores with 95% confidence intervals

		CBT Only				FIT Teens^a
			95%Confidence Interval				95%Confidence Interval
		Adj. Mean	Lower Limit	Upper Limit	Std. Error Mean	Adj. Mean	Lower Limit	Upper Limit	Std. Error Mean	p^b
Functional Disability Inventory	Baseline	24.20	20.56	27.85	1.74	26.95	23.63	30.26	1.58
	Post-Treatment	23.82	18.68	28.97	2.45	18.85	16.24	21.45	1.23	.006
	3-Month Follow-Up	22.69	18.34	27.03	2.07	19.76	16.92	22.60	1.34	.002
Pain VAS	Baseline	6.39	5.63	7.14	0.36	6.57	6.03	7.11	0.26
	Post-Treatment	6.36	5.25	7.47	0.53	4.71	3.62	5.80	0.52	.014
	3-Month Follow-Up	6.26	5.28	7.25	0.47	4.62	3.64	5.60	0.46	.005
Childhood Depression Inventory	Baseline	13.77	10.96	16.57	1.34	16.08	13.30	18.87	1.33
	Post-Treatment	13.67	10.03	17.30	1.73	11.84	9.13	14.55	1.28	.033
	3-Month Follow-Up	12.92	9.31	16.53	1.72	11.39	8.01	14.77	1.59	.024
Pain Catastrophizing Scale	Baseline	23.85	19.92	27.79	1.88	30.50	25.94	35.05	2.18
	Post-Treatment	20.74	15.62	25.87	2.44	19.64	16.00	23.28	1.72	<.001
	3-Month Follow-Up	21.92	17.49	26.35	2.11	19.73	15.23	24.24	2.12	<.001
Tampa Scale of Kinesiophobia	Baseline	25.33	23.05	27.61	1.09	28.52	26.24	30.81	1.09
	Post-Treatment	23.46	21.28	25.63	1.04	23.37	21.58	25.16	0.84	<.001
	3-Month Follow-Up	24.19	21.43	26.95	1.31	22.67	19.99	25.36	1.27	.001

Within groups MANOVA only conducted for the FIT Teens groups due to non-overlapping confidence intervals in post-hoc analyses

All comparisons are to baseline levels (i.e., Post-Treatment vs. Baseline, 3-Month Follow-up vs. Baseline); all p-values reported are significant at the .05 level after False Discovery Rate Type-1 error control.